-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OXFIOtu9o0CO7mqrI5knuEocauD6bcOwh5nVeI8RBQA01QXP206uXC0nwjbnB7Po PZRPkeFyw7mMdRBlsXkg3g== 0001179110-05-000869.txt : 20050110 0001179110-05-000869.hdr.sgml : 20050110 20050110173543 ACCESSION NUMBER: 0001179110-05-000869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050106 FILED AS OF DATE: 20050110 DATE AS OF CHANGE: 20050110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREGG TERRANCE H CENTRAL INDEX KEY: 0001236388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22623 FILM NUMBER: 05521745 BUSINESS ADDRESS: BUSINESS PHONE: 8585522200 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OCULAR SCIENCES INC /DE/ CENTRAL INDEX KEY: 0000882484 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942985696 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1855 GATEWAY BLVD STREET 2: SUITE 700 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 1-925-969-7000 MAIL ADDRESS: STREET 1: 1855 GATEWAY BLVD STREET 2: SUITE 700 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: O S I CORP DATE OF NAME CHANGE: 19970506 4 1 edgar.xml FORM 4 - X0202 4 2005-01-06 1 0000882484 OCULAR SCIENCES INC /DE/ OCLR 0001236388 GREGG TERRANCE H 1855 GATEWAY BOULEVARD SUITE 700 CONCORD CA 94520 1 0 0 0 Common Stock 2005-01-06 4 D 0 1000 0 D 0 D Director Stock Option (right to buy) 18.00 2005-01-06 4 D 0 30000 54.51 D 2009-11-19 Common Stock 30000 0 D Director Stock Option (right to buy) 11.94 2005-01-06 4 D 0 15000 60.57 D 2010-08-04 Common Stock 15000 0 D Director Stock Option (right to buy) 21.00 2005-01-06 4 D 0 15000 51.51 D 2011-08-01 Common Stock 15000 0 D Director Stock Option (right to buy) 25.13 2005-01-06 4 D 0 15000 47.38 D 2012-08-12 Common Stock 15000 0 D Director Stock Option (right to buy) 20.32 2005-01-06 4 D 0 10000 52.19 D 2013-08-01 Common Stock 10000 0 D Director Stock Option (right to buy) 44.79 2005-01-06 4 D 0 10000 27.72 D 2014-08-02 Common Stock 10000 0 D Disposed of pursuant to Merger Agreement among The Cooper Companies, Inc. ("Cooper"), TCC Acquisition Corp. and issuer ("Merger Agreement") in exchange for (i)387 shares of Cooper Common Stock, having a market value of $72.51 per share, and (ii)$22,000 cash, on the effective date of the merger. Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning December 31, 1999 was accelerated and canceled in exchange for $423,000.22 and 7,458 shares of Cooper common stock, having a market value of $72.51 per share. Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning September 30, 1999, was accelerated and canceled in exchange for $251,411.53 and 4,432 shares of Cooper common stock, having a market value of $72.51 per share. Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning September 30, 2001, was accelerated and canceled in exchange for $191,750.13 and 3,380 shares of Cooper common stock, having a marekt value of $72.51 per share. Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning September 30, 2002, was accelerated and canceled in exchange for $164,560.99 and 2,901 shares of Cooper common stock, having a market value of $72.51 per share. Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning September 30, 2003, was accelerated and canceled in exchange for $130,817.86 and 2,306 shares of Cooper common stock, having a market value of $72.51 per share. Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning September 30, 2004 was accelerated and canceled in exchange for $23,421.85 and 412 shares of Cooper common stock, having a market value of $72.51 per share. This combination of cash and Cooper common stock represents the per share value of the merger consideration ($72.51 per share) minus the exercise price of the option, multiplied by the number of shares of issuer common stock subject to such option. Greg Zimmerman, Attorney-In-Fact 2005-01-10 -----END PRIVACY-ENHANCED MESSAGE-----